SG Americas Securities’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,483
| Closed | -$244K | – | 3027 |
|
|
2024
Q3 | $244K | Buy |
+13,483
| New | +$244K | ﹤0.01% | 2071 |
|
|
2024
Q2 | – | Sell |
-18,873
| Closed | -$200K | – | 2739 |
|
|
2024
Q1 | $200K | Buy |
18,873
+803
| +4% | +$8.51K | ﹤0.01% | 1756 |
|
|
2023
Q4 | $165K | Buy |
18,070
+5,906
| +49% | +$53.9K | ﹤0.01% | 2131 |
|
|
2023
Q3 | $126K | Buy |
+12,164
| New | +$126K | ﹤0.01% | 2393 |
|
|
2023
Q2 | – | Sell |
-11,328
| Closed | -$81K | – | 2606 |
|
|
2023
Q1 | $81K | Buy |
+11,328
| New | +$81K | ﹤0.01% | 2711 |
|
|
2021
Q4 | – | Sell |
-8,420
| Closed | -$270K | – | 3258 |
|
|
2021
Q3 | $270K | Buy |
+8,420
| New | +$270K | ﹤0.01% | 2776 |
|
|
2020
Q3 | – | Sell |
-5,858
| Closed | -$193K | – | 2720 |
|
|
2020
Q2 | $193K | Buy |
+5,858
| New | +$193K | ﹤0.01% | 2494 |
|